Eli Lilly and Company LLY.TO
Set alert
50.51 CAD +1.62 +3.31%
As of Oct 30, 3:59 PM ET
50.20 Day range 51.66
30.67 52-week range 51.66
- YTD
- +29.25%
- 1 year
- +29.25%
- Open
- 50.27
- Prev close
- 48.89
- Mkt cap
- 1.65T
- Vol
- 170.78K
- Avg vol
- 78.76K
- EPS
- 1.09
- P/E
- 46.34
- Div yield
- 0.00%
More statistics
- Low
- 50.20
- High
- 51.66
- Forward P/E
- 0.00
- Beta
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 42.72
- 200-d avg
- 39.17
2Y chart
Signals (35)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 3 days ago |
| RSI: Overbought | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jul 3, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| RSI: Overbought | May 28, 2026 | 5 months ago |
| RSI: Overbought | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| RSI: Oversold | Mar 20, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 1.15T
- Trailing P/E
- 48.10
- Forward P/E
- 0.00
- PEG ratio
- 0.42
- Price / sales
- 0.00
- Price / book
- 30.79
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 33.53%
- Total cash
- 0
- Total debt
- 62
- Return on equity
- 92.58%
- 50-day average
- 42.72
- 200-day average
- 39.17
Next earnings
Consensus EPS estimate 0.00.
About Eli Lilly and Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- US
- Employees
- 50,000
- Website
- lilly.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LLY.TO — it syncs with the Stock Master app.